Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: A pilot trial

American Journal of Critical Care

Volumn 19, Issue 3, 2010, Pages

  Frohmader, Terence J ^a   Chaboyer, Wendy P ^b   Robertson, Iain K ^c,d   Gowardman, John ^e  

^a LAUNCESTON GENERAL HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d Clifford Craig Medical Research Trust   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

AGED; ARTICLE; AUSTRALIA; BIFIDOBACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIARRHEA; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; HUMAN; INCIDENCE; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; MALE; MIDDLE AGED; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; TREATMENT OUTCOME;

AGED; AUSTRALIA; BIFIDOBACTERIUM; CRITICAL ILLNESS; DIARRHEA; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; HUMANS; INCIDENCE; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; STREPTOCOCCUS THERMOPHILUS; TREATMENT OUTCOME;

EID: 77955287649     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2010976     Document Type: Article

References (50)

1. Montejo J. Enteral nutrition-related gastrointestinal complications in critically ill patients: a multicenter study. The Nutritional and Metabolic Working Group of the Spanish Society of Intensive Care Medicine and Coronary Units. Crit Care Med. 1999;27(8):1447-1453.
2. Smith C, Marien L, Brogdon C, et al. Diarrhea associated with tube feeding in mechanically ventilated critically ill patients. Nurs Res. 1990;39(3):148-152.
3. Bleichner G, Thomas O, Sollet J. Diarrhea in intensive care: diagnosis and treatment. Int J Antimicrob Agents. 1993;3(1): 33-48.
4. Dobb GJ. Diarrhea in the critically ill. Intensive Care Med. 1986;11:7-9.
5. Adam S, Batson S. A study of problems associated with the delivery of enteral feed in critically ill patients in five ICUs in the UK. Intensive Care Med. 1997;23:261-266.
6. Majid HA, Emery PW, Whelan K. Attitudes of patients and nurses towards diarrhoea during tube feeding [abstract]. J Hum Nutr Diet. 2008;21(4):395.
7. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr. 2001;73(2 suppl):444S-450S.
8. Pessi T, Sütas Y, Saxelin M, Kallioinen H, Isolauri E. Antipro-liferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol. 1999;65(11):4725-4728.
9. Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr. 2001;20(2 suppl):149-156.
10. Zamfir M, Callewaert R, Cornea PC, Savu L, Vatafu I, De Vuyst L. Purification and characterization of a bacteriocin produced by Lactobacillus acidophilus IBB 801. J Appl Microbiol. 1999;87(6):923-931.
11. Goldin B, Gorbach S, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci. 1992;37(1):121-128.
12. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lac-tobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002;109:678-684.
13. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med. 2002;346:334-339.
14. Szajewska H, Mrukowicz J. Probiotics in the treatment and prevention of acute infectious diarrhoea in infants and children; a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001;33(suppl 2):17-25.
15. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007;5(2):97-105.
16. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997; 99:179-185.
17. Delia P, Sansotta G, Donato V, et al, Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol. 2007;13(6):912-915.
18. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119(2):584-587.
19. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53(1):108-114.
20. Fedorak RN, Gionchetti P, Campieri M, et al. VSL3 probiotic mixture induces remission in patients with active ulcerative colitis [abstract]. Gastroenterology. 2003;124(4 suppl 1):A377.
21. Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 2005;100:1539-1546.
22. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic-associated diarrhoea: meta-analysis. BMJ. 2002;324:1361-1367.
23. Hickson M, D'Souza A, Muthu N, et al. Use of probiotic lac-tobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335(7610):80.
24. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostrid-ium difficile disease. Am J Gastroenterol. 2006;101:812-822
25. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhea. Int Microbiol. 2004;7(1):59-62.
26. Anderson AD, McNaught CE, Jain PK, MacFie J. Randomised clinical trial of symbiotic therapy in elective surgical patients. Gut. 2004;53(2):241-245.
27. McNaught CE, Woodcock N P, MacFie J, Mitchell CJ. A prospective randomised study of the probiotic Lactobacil-lus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut. 2002;51(6):827-831.
28. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2002;16(8):1461-1467.
29. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans L F. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev. 2004;(2):CD003048.
30. Bleichner G, Bléhaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients: a multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med. 1997;23(5):517-523.
31. Whelan K. Enteral-tube feeding diarrhea: manipulating the colonic microbiota with probiotics and prebiotics. Proc Nutr Soc. 2007;66:299-306.
32. Whelan K, Judd P, Tuoy K, Gibson G, Preedy V, Taylor M. Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am J Clin Nutr. 2009;89:240-247.
33. Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med. 1998;129(12):1012-1019.
34. Okuma T, Nakamura M, Totake H, Fukanaga, Y. Microbial contamination of enteral feeding formulas and diarrhea. Nutrition. 2000;16(9):719-722.
35. Seifert C F, Johnston BA. A nationwide survey of long-term care facilities to determine the characteristics of medication administration through enteral feeding catheters. Nutr Clin Pract. 2005;20:354-362.
36. Hwang TL, Lue MC, Nee YJ, Jan YY, Chen M F. The incidence of diarrhea in patients with hypoalbuminemia due to acute or chronic malnutrition during enteral feeding. Am J Gastroenterol. 1994;89(3):376-378.
37. Bowling TE, Raimundo AH, Gimble GK, Silk DB. Colonic secretory effect in response to enteral feeding in humans. Gut. 1994;35:1734-1741.
38. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinva-sive Escherichia coli (EIEC). Gut. 2003;52(7):988-997.
39. Bowling TE, Raimundo AH, Gimble GK, Silk DB. Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet. 1993;342:1266-1268.
40. Alberda C, Gramlich L, Meddings J, et al. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2007;85(3):816-823.
41. Heimburger D, Sockwell D, Geels W. Diarrhea with enteral feeding: prospective reappraisal of putative causes. Nutrition. 1994;10(5):392-396.
42. Whelan K, Judd PA, Taylor MA. Assessment of fecal output in patients receiving enteral tube feeding: validation of a novel chart. Eur J Clin Nutr. 2004;58(7):130-137.
43. World Health Organization. The Treatment of Diarrhoea: A Manual for Physicians and Senior Health Workers. 4th rev. Geneva, Switzerland: World Health Organization, Division of Diarrhoeal and Acute Respiratory Disease Control; 2005.
44. Lebak K, Bliss D, Savik K, Patten-Marsh K. What's new on defining diarrhea in tube-feeding studies? Clin Nurs Res. 2003;12(2):174-204.
45. Gupta V, Garg R. Probiotics. Indian J Med Microbiol. 2009; 27(3):202-209.
46. Timmerman H, Niers L, Ridwan B, et al. Design of multi-species probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr. 2007;26(4):450-459.
47. Venturi A, Gionchetti P, Rizzello F, et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther. 1999;13(8): 1103-1108.
48. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115(1):178-181.
49. Salminen MK, Rautelin H, Tynkkynen S, et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 2004;38(1):62-69.
50. Besselink, M, van Santvoort H, Buskens E, et al; Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial [published correction appears in Lancet. 2008;371(9620):1246]. Lancet. 2008;371(9613):651-659.